Cashu | GPCR | News

HomeWatchlistNewsSignalsPicks

DJI

+1.34%

SPX

+0.21%

IXIC

-0.26%

FTSE

+0.44%

N225

+1.37%

AXJO

+1.23%

⌘K

HomeWatchlistNewsSignals

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Stocks

Health Care

gpcr

Structure Therapeutics

NASDAQ: GPCR

-1.45 (-2.10%)

67.49

USD

At close at Dec 11, 21:45 UTC

Latest Structure Therapeutics News

A Closer Look at Structure Therapeutics's Options Market Dynamics

Feature Image for interests on Bzi-Uoa, Financial Services, Markets, Options from benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

Feature Image for interests on Bzi-Tfm, Financial Services, Healthcare, Movers from benzinga.com

What's Going On With Structure Therapeutics (GPCR) Stock Today?

Feature Image for interests on Movers, News, Stock, Unknown Sector from benzinga.com

Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana And Other Big Stocks Moving Higher On Monday

Feature Image for interests on Basic Materials, Big Gainers, Consumer Cyclical, Healthcare from benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

Feature Image for interests on Bzi-Tfm, Financial Services, Healthcare, Movers from benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

about 1 month ago

New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data

Feature Image for interests on Ai Generated, Healthcare, Obesity, Stock from benzinga.com

G-Protein Coupled Receptor (GPCR) Targeting Technologies Market on the Rise

Feature Image for interests on Biotechnology, Consumer Staples, Health Care & Hospitals, Market Research Reports from prnewswire.com

Domain Therapeutics to Present Data on its GPCR Lead Programs at AACR Annual Meeting 2025

businesswire.com

CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Feature Image for interests on Stock, Unknown Sector from businesswire.com

Join our newsletter to keep up to date with us!

Latest Cashu News

Structure Therapeutics at AACR 2025: Promising Innovations in Cancer Therapies

Exicure Acquires GPCR Therapeutics to Enhance Hematology Focus and Innovation

Exicure Acquires GPCR USA to Enhance R&D and Boost Therapeutic Innovations